Brainstorm Cell Therapeutics (BCLI) Insider Trading & Ownership

$0.55
+0.02 (+3.81%)
(As of 04/24/2024 ET)

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.45%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$20,355.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BCLI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCLI Insider Buying and Selling by Quarter

Brainstorm Cell Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/1/2023Stacy LindborgCEOBuy11,500$1.77$20,355.00  
(Data available from 1/1/2013 forward)

BCLI Insider Trading Activity - Frequently Asked Questions

Who is on Brainstorm Cell Therapeutics's Insider Roster?

The list of insiders at Brainstorm Cell Therapeutics includes Stacy Lindborg. Learn more on insiders at BCLI.

What percentage of Brainstorm Cell Therapeutics stock is owned by insiders?

5.45% of Brainstorm Cell Therapeutics stock is owned by insiders. Learn more on BCLI's insider holdings.

Which Brainstorm Cell Therapeutics insiders have been buying company stock?

The following insider purchased BCLI shares in the last 24 months: Stacy Lindborg ($20,355.00).

How much insider buying is happening at Brainstorm Cell Therapeutics?

Insiders have purchased a total of 11,500 BCLI shares in the last 24 months for a total of $20,355.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:BCLI) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners